Strain AI vs Tempus ECG-Low EF
AI Verdict
Choose Strain AI if…
Choose Strain AI if you require real-time, quantitative assessment of cardiac function directly from ultrasound images, particularly for detailed evaluation of Global Longitudinal Strain (GLS). This tool is ideal for clinicians who need immediate, on-device AI insights to aid in diagnosing heart failure or cardiotoxicity in adult patients, especially in settings where internet connectivity might be limited.
View Strain AI →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if you need a rapid, AI-powered screening tool to identify patients 40 years or older at risk of heart failure by analyzing standard 12-lead ECG recordings. This software is best suited for integrating into existing healthcare facility workflows to quickly flag individuals with potential low left ventricular ejection fraction (LVEF ≤40%) for further diagnostic workup.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Strain AI | Tempus ECG-Low EF |
|---|---|---|
| Deployment | API, Integrations with POS and menu sync platforms (Dutchie, Leafly, Weedmaps, Jane POS, Treez) | Integrates with current ECG platforms and electronic health records (EHRs). |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Strain AIStrain AI offers real-time, on-device AI insights that operate without an internet connection and integrate with existing ultrasound devices, providing a seamless and immediate user experience at the point of care. This direct, integrated approach simplifies the workflow for clinicians by eliminating external dependencies and processing delays.
Clinical Value
Strain AIWhile both tools are FDA-cleared and address critical cardiac conditions, Strain AI measures Global Longitudinal Strain (GLS) from cardiac ultrasound images, which is a more sensitive and earlier indicator of myocardial dysfunction than ejection fraction. This allows for earlier detection of conditions like heart failure with preserved ejection fraction (HFpEF) and cardiotoxicity, providing quantitative diagnostic aid. Tempus ECG-Low EF provides a binary output for screening and risk stratification, but is not a stand-alone diagnostic tool and requires further evaluation.
Pricing & Value
TieBoth Strain AI and Tempus ECG-Low EF explicitly state 'contact for pricing' or 'contact vendor,' making it impossible to conduct a head-to-head comparison of their cost-effectiveness or value propositions based on the available information. Without transparent pricing models, a definitive winner cannot be determined.
Enterprise Readiness
Tempus ECG-Low EFBoth tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), demonstrating strong foundational enterprise readiness. However, Tempus ECG-Low EF explicitly focuses on integration into existing healthcare facility workflows and partnerships with Electronic Health Record (EHR) providers, indicating a more comprehensive strategy for large-scale IT integration and data flow within an enterprise environment.
Innovation
Strain AIStrain AI's ability to deliver real-time, on-device Global Longitudinal Strain (GLS) analysis on a handheld ultrasound device represents a significant innovation in point-of-care diagnostics. This capability provides instant, bedside cardiac insights without relying on cloud processing, pushing the boundaries of immediate diagnostic accessibility.
Support & Docs
TieBoth companies provide standard customer support channels, including phone and email contact, and offer access to documentation such as user manuals and release notes. Neither tool's information provides sufficient detail to differentiate the depth, responsiveness, or comprehensiveness of their support and documentation offerings.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Strain AI | Tempus ECG-Low EF |
|---|---|---|
| Name | Strain AI | Tempus ECG-Low EF |
| Company | Exo | Tempus AI |
| Description | AI-powered medical software that analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS), aiding physicians in assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients. | AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. |
| Input Data | Cardiac ultrasound images | 12-lead ECG recordings |
| Key Measurement/Detection | Global Longitudinal Strain (GLS) | Low Left Ventricular Ejection Fraction (LVEF u226440%) |
| Target Patient Population | Adult patients | Patients 40 years or older at risk of heart failure |
| Primary Use Case | Assessing heart function and detecting conditions like heart failure and cardiotoxicity | Aiding clinicians in further evaluation for low LVEF and heart failure risk |
| Output | Quantitative strain measurements, real-time, on-device AI insights | Binary output (Low LVEF Detected / Not Detected) |
Videos
Demos, reviews, and walkthroughs featuring Strain AI and Tempus ECG-Low EF.
Frequently Asked Questions
More Comparisons
More matchups featuring Strain AI or Tempus ECG-Low EF
Backers
Who funded each tool's parent company.